Zueva IV - Search Results

1

Delivery nanosystems based on sterically hindered phenol derivatives containing a quaternary ammonium moiety: Synthesis, cholinesterase inhibition and antioxidant activity.

Pashirova TN, Burilova EA, Tagasheva RG, Zueva IV, Gibadullina EM, Nizameev IR, Sudakov IA, Vyshtakalyuk AB, Voloshina AD, Kadirov MK, Petrov KA, Burilov AR, Bukharov SV, Zakharova LY. Pashirova TN, et al. Among authors: zueva iv. Chem Biol Interact. 2019 Sep 1;310:108753. doi: 10.1016/j.cbi.2019.108753. Epub 2019 Jul 15. Chem Biol Interact. 2019. PMID: 31319075

2

Study of hepatoprotective effects of xymedon.

Vyshtakalyuk AB, Nazarov NG, Zueva IV, Lantsova AV, Minnekhanova OA, Busygin DV, Porfiryev AG, Evtyugin VG, Reznik VS, Zobov VV. Vyshtakalyuk AB, et al. Among authors: zueva iv. Bull Exp Biol Med. 2013 Sep;155(5):643-6. doi: 10.1007/s10517-013-2215-0. Bull Exp Biol Med. 2013. PMID: 24288729

3

6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS. Semenov VE, et al. Among authors: zueva iv. ChemMedChem. 2015 Nov;10(11):1863-74. doi: 10.1002/cmdc.201500334. Epub 2015 Sep 28. ChemMedChem. 2015. PMID: 26412714

4

Luminescent silica nanoparticles for sensing acetylcholinesterase-catalyzed hydrolysis of acetylcholine.

Mukhametshina AR, Fedorenko SV, Zueva IV, Petrov KA, Masson P, Nizameev IR, Mustafina AR, Sinyashin OG. Mukhametshina AR, et al. Among authors: zueva iv. Biosens Bioelectron. 2016 Mar 15;77:871-8. doi: 10.1016/j.bios.2015.10.059. Epub 2015 Oct 22. Biosens Bioelectron. 2016. PMID: 26516688 Free article.

5

6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.

Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS. Zueva IV, et al. Int J Risk Saf Med. 2015;27 Suppl 1:S69-71. doi: 10.3233/JRS-150694. Int J Risk Saf Med. 2015. PMID: 26639718

6

Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment.

Kharlamova AD, Lushchekina SV, Petrov KA, Kots ED, Nachon F, Villard-Wandhammer M, Zueva IV, Krejci E, Reznik VS, Zobov VV, Nikolsky EE, Masson P. Kharlamova AD, et al. Among authors: zueva iv. Biochem J. 2016 May 1;473(9):1225-36. doi: 10.1042/BCJ20160084. Epub 2016 Feb 29. Biochem J. 2016. PMID: 26929400

7

Novel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile.

Strelnik AD, Petukhov AS, Zueva IV, Zobov VV, Petrov KA, Nikolsky EE, Balakin KV, Bachurin SO, Shtyrlin YG. Strelnik AD, et al. Among authors: zueva iv. Bioorg Med Chem Lett. 2016 Aug 15;26(16):4092-4. doi: 10.1016/j.bmcl.2016.06.070. Epub 2016 Jun 25. Bioorg Med Chem Lett. 2016. PMID: 27377327

8

Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity.

Pashirova TN, Zueva IV, Petrov KA, Babaev VM, Lukashenko SS, Rizvanov IK, Souto EB, Nikolsky EE, Zakharova LY, Masson P, Sinyashin OG. Pashirova TN, et al. Among authors: zueva iv. ACS Appl Mater Interfaces. 2017 May 24;9(20):16922-16932. doi: 10.1021/acsami.7b04163. Epub 2017 May 15. ACS Appl Mater Interfaces. 2017. PMID: 28504886

9

C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies.

Petrov K, Zueva I, Kovyazina I, Sedov I, Lushchekina S, Kharlamova A, Lenina O, Koshkin S, Shtyrlin Y, Nikolsky E, Masson P. Petrov K, et al. Neuropharmacology. 2018 Mar 15;131:304-315. doi: 10.1016/j.neuropharm.2017.12.034. Epub 2017 Dec 24. Neuropharmacology. 2018. PMID: 29277489 Free article.

10

Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment.

Petrov KA, Kharlamova AD, Lenina OA, Nurtdinov AR, Sitdykova ME, Ilyin VI, Zueva IV, Nikolsky EE. Petrov KA, et al. Among authors: zueva iv. Sci Rep. 2018 Jan 10;8(1):304. doi: 10.1038/s41598-017-18307-9. Sci Rep. 2018. PMID: 29321572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters